PIM1: a promising target in patients with triple-negative breast cancer.

about

Synthesis of new pyridothienopyrimidinone and pyridothienotriazolopyrimidine derivatives as pim-1 inhibitors.Pim1 promotes cell proliferation and regulates glycolysis via interaction with MYC in ovarian cancer

P2860

Q47378160-73517589-5997-41B5-B920-165D2DE7286E Q57817294-DDCB828E-CCC9-4CAE-AF8D-0C4E234F3AC2

P2860

PIM1: a promising target in patients with triple-negative breast cancer.

Item

http://www.wikidata.org/entity/Q39443294

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

PIM1: a promising target in patients with triple-negative breast cancer.

@en

PIM1: a promising target in patients with triple-negative breast cancer.

@nl

type

Item

label

PIM1: a promising target in patients with triple-negative breast cancer.

@en

PIM1: a promising target in patients with triple-negative breast cancer.

@nl

prefLabel

PIM1: a promising target in patients with triple-negative breast cancer.

@en

PIM1: a promising target in patients with triple-negative breast cancer.

@nl

P1476

PIM1: a promising target in patients with triple-negative breast cancer

@en

P2093

Pan Li

http://www.w3.org/2001/XMLSchema#string

RuiYue Qiu

http://www.w3.org/2001/XMLSchema#string

Wen Zhao

http://www.w3.org/2001/XMLSchema#string

P2860

Pim kinases promote cell cycle progression by phosphorylating and down-regulating p27Kip1 at the transcriptional and posttranscriptional levels

Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors

PIM serine/threonine kinases in the pathogenesis and therapy of hematologic malignancies and solid cancers

c-Myc regulates transcriptional pause release

Pim1 kinase synergizes with c-MYC to induce advanced prostate carcinoma

Genomic targets of the human c-Myc protein

Physical and functional interactions between Pim-1 kinase and Cdc25A phosphatase. Implications for the Pim-1-mediated activation of the c-Myc signaling pathway

Regulation of Pim-1 by Hsp90

The PIM-2 kinase phosphorylates BAD on serine 112 and reverses BAD-induced cell death

Phosphorylation of the cell cycle inhibitor p21Cip1/WAF1 by Pim-1 kinase

P2888

s12032-017-0998-y

P304

142

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12032-017-0998-Y

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jin Yang

P577

2017-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28721678

http://www.w3.org/2001/XMLSchema#string

PIM1: a promising target in patients with triple-negative breast cancer.

about

P2860

P2860

PIM1: a promising target in patients with triple-negative breast cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698